Unlock Exclusive Discounts & Flash Sales! Click Here to Join the Deals on Every Wednesday!
The administration of therapeutic biologic drugs can induce anti-drug antibody(ADA) immune responses in study subjects. These immune responses can produce a range of effects from benign and asymptomatic to altered pharmacokinetics and/or pharmacodynamics and adverse clinical sequelae. To date, all ADA assay technologies are prone to false-negative results due to interference caused by drug that remains in circulation after dosing.